India will wait and watch the situation emanating from the imposition of additional import duties by the US on the global trade and not take any action in a hurry as America may itself face......
The Pharmaceuticals Export Promotion Council of India, a body under the ministry of commerce, on Friday suspended the membership of Marion Biotech after the company failed to reply to it on the......
Rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs. Photograph: Yves Herman/Reuters The......
The government on Tuesday proposed to fully exempt three cancer medicines from customs duties. The government proposes to cut customs duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab......
Asserting that India follows a zero-tolerance policy on spurious medicines, Union health minister Mansukh Mandaviya has said 71 companies have been issued show-cause notices following concerns......
Indian pharmaceutical companies may have units abroad as part of “distributed manufacturing” across various locations, according to industry veterans. Illustration: Uttam......
The Indian exporting community is "very" concerned about the possible reciprocal tariffs of the US as it could severely hurt MSME shipments to America in the short run, Federation of Indian Export......
Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with......
Investors should tilt their portfolios towards domestic-facing defensive sectors, which should help provide stability and shield them from geopolitical and tariff risks. Illustration: Uttam......
The heightened global uncertainty due to the US "reciprocal tariffs" on India may cause near-term corrections and market turbulence, but the long-term outlook remains constructive, market experts......